European Footprint Singota has expanded into Europe with new facilities in Italy and Switzerland, creating a regional footprint that enables nearshore manufacturing, faster cross-border supply chains, and streamlined regulatory alignment for European customers.

Cold Chain Capacity The Milan area facility includes ultra-cold storage (-40°C and -20°C) and aseptic manufacturing capabilities, enabling Singota to handle temperature-sensitive biologics and vaccines and offer end-to-end cold-chain services to sponsors.

Comprehensive Services As a cGMP compliant, FDA-registered CDMO offering formulation development, supply chain and materials management, analytical testing, labeling and kitting, and aseptic manufacturing, Singota provides a single partner to support products from bench to market, creating cross-sell opportunities across existing client relationships.

Risk Management Edge The Risk Knowledge Infinity framework introduced in 2024 positions Singota as a risk-reduction partner for risk-averse clients, appealing to sponsors seeking structured, proactive risk management in formulation and process development.

Onshoring Growth Leadership emphasis on onshoring and Indiana manufacturing roots, combined with European expansion, creates a compelling narrative for North American firms seeking domestic or nearshore partnerships to improve supply chain resilience and time-to-market.